WPI Insider Trading Activity and SEC Form 4 Filings
WPI insider trading summary
No open-market insider purchases or sales of Watson Pharmaceuticals Inc (WPI) have been reported on SEC Form 4 in the past 12 months.
Latest WPI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 30, 2012 | Michel J Feldman | Director | Sell | $41K (500 @ $81.78) |
| Aug 30, 2012 | Michel J Feldman | Director | Sell | $407K (5,000 @ $81.46) |
| Aug 24, 2012 | David A Buchen | Chief Legal Officer-Global&Sec | Sell | $2.0M (24,294 @ $81.56) |
| Aug 1, 2012 | R Todd Joyce | CFO-Global & PAO | Sell | $205K (2,612 @ $78.60) |
| Aug 1, 2012 | R Todd Joyce | CFO-Global & PAO | Sell | $177K (2,250 @ $78.60) |
| Aug 1, 2012 | R Todd Joyce | CFO-Global & PAO | Sell | $345K (4,388 @ $78.60) |
| Aug 1, 2012 | R Todd Joyce | CFO-Global & PAO | Sell | $45K (574 @ $78.60) |
| Jul 31, 2012 | Cathy Klema | Director | Sell | $392K (5,000 @ $78.38) |
| Jul 31, 2012 | Cathy Klema | Director | Sell | $392K (5,000 @ $78.38) |
| Jul 31, 2012 | Cathy Klema | Director | Sell | $917K (11,700 @ $78.38) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.